References
- American Academy for Cerebral Palsy and Developmental Medicine Sialorrhea Care Pathway Team: Glader, L. Delsing, C. Hughes, A. Parr, J. Pennington, L. Reddihough, D. van Hulst, K. van der Burg, J.
Sialorrhea in cerebral palsy care pathway.
2018 Available from:
https://www.aacpdm.org/publications/care-pathways/sialorrhea-in-cerebral-palsy - Ari, A.B. Peri, T. Margalit, D. Galili‑Weisstub, E. Udassin, R. Benarroch, F.
Surgical procedures and pediatric medical traumatic stress (PMTS) syndrome: Assessment and future directions.
J Pediatr Surg. 2018;53(8):1526‑1531 - Banerjee, K.J. Glasson, C. O’Flaherty, S.J.
Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
Developmental Medicine & Child Neurology. 2006;48:883–887 - Batchelor, H.K. Marriott, J.F.
Formulations for children: problems and solutions.
Br J Clin Pharmacol. 2013;79(3):405–18 - Bavikatte, G. Lin Sit, P. Hassoon, A.
Management of drooling of saliva.
BJMP. 2012;5(1):a507 - Begley, K. A. Braswell, L. E. Noritz, G. H. Murakami, J. W.
Salivary gland ablation: introducing an interventional radiology treatment alternative in the management of sialorrhea.
Pediatric Radiology. 2020; 50:869–876 - Calim, O.F. Hassouna, H.N. Yildirim, Y.S. Dogan, R. Ozturan, O.
Pediatric Sialorrhea: Submandibular duct rerouting and intraparotid botulinum toxin A injection with literature review.
Annals of Otology, Rhinology & Laryngology. 2019;128(2):104‑112 - Chaléat‑Valayer, E. Porte, M. Buchet‑Poyau, K. Roumenoff‑Turcant, F. D'Anjou, M. C. Boulay, C. Bernard, J. C. Touzet, S.
Management of drooling in children with cerebral palsy: A French survey.
European Journal of Paediatric Neurology. 2016;20(4):524‑531 - Clinigen Healthcare Ltd.
Rybrila Glycopyrronium Bromide 1 mg/5 ml Oral Solution
Summary of Product Characteristics. - Collins, A. Burton, A. Fairhurst, C.
Management of drooling in children with cerebral palsy.
Paediatrics and Child Health. 2020 - Dritsoula, A. K. Greenstreet, D. Thevasagayam, M. S.
The drooling child
BMJ. 2015;350:h38 - EMEA – CHMP Reflection Paper:
Formulations of choice for the paediatric population.
July 2006 EMEA/CHMP/PEG/194810/200. Available from:
https://www.ema.europa.eu/en/formulations‑choice‑paediatric‑population - Fairhurst, C.B. Cockerill, H.
Management of drooling in children.
Arch Dis Child Educ Pract Ed. 2011;96(1):25‑30 - Hernández‑Palestina, M.S. Cisneros‑Lesser, J.C. Arellano‑Saldaña , M.E. Plascencia‑Nieto, S.E.
Submandibular gland resection for the management of sialorrhea in paediatric patients with cerebral palsy and unresponsive to type A botullinum toxin.
Pilot study. Cirugía y Cirujanos (English Edition). 2016;84(6):459‑468 - Humphrey, S.P. Williamson, R.T.
A review of saliva: Normal composition, flow, and function.
The Journal of Prosthetic Dentistry. 2001;85:162‑9 - Kok, S. E. van der Burg, J. J. W. van Hulst, K. Erasmus, C. E. van den Hoogen, F. J. A.
The impact of submandibular duct relocation on drooling and the well‑being of children with neurodevelopmental disabilities.
International Journal of Pediatric Otorhinolaryngology. 2016;88:173‑8 - Little, S. A. Kubba, H. Hussain, S. S. M.
An evidence‑based approach to the child who drools saliva
Clinical Otolaryngology. 2009;34(3):236‑239 - Martínez‑Poles, J. Nedkova‑Hristova, V. Escribano‑Paredes, J.B. García‑Madrona, S. NateraVillalba, E. Estévez‑Fraga, C. López‑Sendón Moreno, J.L. Avilés‑Olmos, I. Sánchez Díaz, G. Castrillo, J.C.M. Alonso‑Canovas, A.
Incobotulinumtoxin A for sialorrhea in neurological disorders: A real‑life experience.
Toxins (Basel). 2018;10(6):217 - Meningaud, J.P. Pitak‑Arnnop, P. Chikhani, L. Bertrand, J.C.
Drooling of saliva: a review of the etiology and management options.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2006;101(1):48‑57 - Mier, R. J. Bachrach, S. J. Lakin, R. C. Barker, T. Childs, J. Moran, M.
Treatment of sialorrhoea with glycopyrrolate: A double‑blind, dose‑ranging study.
Arch Pediatr Adolesc Med. 2000;154(12):1214–1218 - Miranda‑Rius, J. Brunet‑Llobet, L. Lahor‑Soler, E. Farré, M.
Salivary Secretory Disorders, Inducing Drugs, and Clinical Management.
International Journal of Medical Sciences. 2015;12(10):811‑824 - Nationwide Children’s.
Sialorrhea (Excessive Drooling).
Available from:
https://www.nationwidechildrens.org/conditions/sialorrhea - Parr, J.R. Todhunter, E. Pennington, L. Stocken, D. Cadwgan, J. O’Hare, A. E. Tuffrey, C. Williams, J. Cole, M. Colver, A. F.
Drooling Reduction Intervention randomised trial (DRI): Comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
Arch Dis Child. 2018;103(4):371–6 - Proctor, G. B. Carpenter, G. H.
Salivary secretion: mechanism and neural regulation
Monogr Oral Sci. 2014;24:14‑29 - Reid, S. M. Johnson, H. M. Reddihough, D. S.
The Drooling Impact Scale: a measure of the impact of drooling in children with developmental disabilities.
Developmental Medicine and Child Neurology. 2010;52(2): e23‑e28 - Reid, S. M. Westbury, C. Guzys, A. T. Reddihough, D. S.
Anticholinergic medications for reducing drooling in children with developmental disability.
Developmental Medicine and Child Neurology. 2019;62(3):346‑353 - Scope.
Advice and Support – Drooling. 2020.
Available from:
https://www.scope.org.uk/advice-and-support/drooling/ - Sousa, S. Rocha, M. Patrão, F. Pereira, G. Reis, S. Horta, P. Salgado, C. dos Santos, M.
Submandibular duct transposition for drooling in children: A Casuistic review and evaluation of grade of satisfaction.
International journal of pediatric otorhinolaryngology. 2018;113:58‑61 - Squires, N. Wills, A. Rowson, J.
The management of drooling in adults with neurological conditions
Current Opinion in Otolaryngology & Head and Neck Surgery. 2012;20(3):171–176. - Thomas, D.R. Cote, T.R. Lawhorne, L. Levenson, S.A. Rubenstein, L.Z. Smith, D.A. Stefanacci, R.G. Tangalos, E.G. Morley, J. E. Dehydration Council.
Understanding Clinical Dehydration and Its Treatment.
Journal of the American Medical Directors Association. 2008;9(5): 292‑301 - van der Burg, J. Jongerius, P. van Limbeek, J. van Hulst, K. Rotteveel, J.
Drooling in children with cerebral palsy: a qualitative method to evaluate parental perceptions of its impact on daily life, social interaction, and self‑esteem.
International Journal of Rehabilitation Research. 2006;29(2):179‑182 - Zeller, R. S. Lee, H‑M. Cavanaugh, P. F. Davidson, J.
Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions.
Ther Clin Risk Manag. 2012;8:15–23 - Zeller, R. S. Davidson, J. Lee, H‑K. Cavanaugh, P. F.
Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions.
Ther Clin Risk Manag. 2012;8:25–32